Unrelated donor bone marrow transplantation for children with acute myeloid leukemia beyond first remission or refractory to chemotherapy Academic Article uri icon

Overview

MeSH Major

  • Antineoplastic Agents
  • Bone Marrow Transplantation
  • Leukemia, Myeloid, Acute

abstract

  • Children who underwent transplantation in remission had a superior outcome compared with children who underwent transplantation during relapse or persistent disease. Nevertheless, 20% of children who underwent transplantation in relapse are long-term survivors, suggesting that unrelated donor bone marrow transplantation is an effective therapy in a significant proportion of children with recurrent or primary refractory AML.

publication date

  • September 10, 2008

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC2653120

Digital Object Identifier (DOI)

  • 10.1200/JCO.2008.16.4442

PubMed ID

  • 18779619

Additional Document Info

start page

  • 4326

end page

  • 32

volume

  • 26

number

  • 26